I find stimulants very helpful. YMMV.
This trial was sponsored by the drug maker, which is OK. In the U.S. this drug is called Sunosi and it costs about $1000/month without insurance,...
Another question for Fluge—why does your phase 2 study only have 10 patients?
I assume or hope we will get some more data in the May meeting in Norway or the one in Germany. Which is why I am hoping someone we know will...
Links not working for me.
https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2827732 Key Points Question Do genes targeted by current treatments for psychiatric...
Here is what JE said Until JE drops the next chapter of the ME/CFS chronicles, that’s about as much as we know.
Hearing from people who knew of people in the Efgart trial that trial was poorly done and that many patients reported getting a lot better,...
Efgart failed for POTS. https://www.s4me.info/threads/efgartigimod-vyvgart-what-could-the-trial-data-possibly-tell-us.37316/ Did they look at...
Correct about Efgartigimod https://pmc.ncbi.nlm.nih.gov/articles/PMC6159959/ Neonatal Fc receptor antagonist efgartigimod safely and...
Cleaned it up a bit
With respect to this thread...
Here is your similar comment regarding IGG for the cyclo study Happy that you are coming over to the dark side now!
Earlier I asked you about this and you said it wasn’t important. IGG measures total antibodies, correct? From both the Fluge cyclo and...
FUNCAP does include questions related to cognitive function, but I don’t see any general questions about energy level or pep.
I don’t like SF 36 10 physical function questions but for completely different reasons. I score in normal healthy human ranges (and won’t vary...
Is there a suggestion that they are going to entertain pseudoscience? I looked at some previous agendas and it looked like there was some (e.g....
Interesting. I’m guessing this is different—Dara kills cells expressing cd38, whereas apigenin inhibits the synthesis of CD38
This is posted under the Scandinavia thread but am posting as a stand alone as the registration deadline is approaching....
Author is familiar with MECFS—see the commentary at the end of this article....
Separate names with a comma.
